Late hematogenous seeding and infection of a femoropopliteal Omniflow II bypass.
Aged
Amputation, Surgical
Blood Vessel Prosthesis
/ adverse effects
Blood Vessel Prosthesis Implantation
/ adverse effects
Femoral Artery
/ surgery
Humans
Male
Peripheral Arterial Disease
/ surgery
Popliteal Artery
/ surgery
Prosthesis Design
Prosthesis-Related Infections
/ diagnosis
Staphylococcal Infections
/ diagnosis
Staphylococcus aureus
/ isolation & purification
Time Factors
Treatment Outcome
Omniflow II
infection
vascular graft
Journal
Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
pubmed:
27
11
2020
medline:
26
11
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
Omniflow II is promoted as an infection-resistant vascular graft. It is used to treat vascular graft infection; nevertheless, early graft infection has been reported.Report: A 71-year-old patient was treated with an Omniflow II bypass for a non-healing diabetic foot ulcer. Seven months postoperatively, late infection occurred secondary to hematogenous spread from a persistent foot infection. We report on the first case of late infection of an Omniflow II vascular graft caused by hematogenous spread. Despite promising results of the Omniflow II graft in the treatment of vascular graft infection, late infection may not be avoided.
Identifiants
pubmed: 33241775
doi: 10.1177/1708538120974151
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM